openPR Logo
Press release

Global Idiopathic Pulmonary Fibrosis to grow at a CAGR of 23.97% during 2016-2020

10-26-2016 05:17 PM CET | Health & Medicine

Press release from: Idiopathic Pulmonary Fibrosis

About Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis belongs to a group of lung diseases known as interstitial lung diseases. It affects people in the age group 50-70 years. Diagnosis is effected by the exclusion of other interstitial lung diseases. High-resolution computed tomography (CT) is often employed to confirm the presence of the disease. There is no permanent cure for this disease; therefore, treatment involves relieving underlying symptoms. Nintedanib and pirfenidone are the two approved drugs for the treatment of idiopathic pulmonary fibrosis. Corticosteroids and immunosuppressive drugs are also used for the treatment.

Technavios analysts forecast the global idiopathic pulmonary fibrosis market to grow at a CAGR of 23.97% during the period 2016-2020.

Download Sample Copy of Report at http://www.marketresearchreports.biz/sample/sample/717645

Covered in this report

The report covers the present scenario and the growth prospects of the global idiopathic pulmonary fibrosis market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used in the treatment of idiopathic pulmonary fibrosis.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Idiopathic Pulmonary Fibrosis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Baxter International
Boehringer Ingelheim
F.Hoffmann-La Roche
Prometheus Laboratories

Other prominent vendors
Afferent Pharmaceuticals
Amgen
Biogen
Bristol-Myers Squibb
Cipla
FibroGen
Gilead Sciences
GlaxoSmithKline
GNI Group
Horizon Pharma
ImmuneWorks
MediciNova
MedImmune (subsidiary of AstraZeneca)
Novartis
Pfizer
Promedior
ProMetic Life Sciences
Sanofi
Shionogi
Zai Lab

Market driver
Unmet medical need
For a full, detailed list, view our report

Market challenge
Lack of proper diagnosis
For a full, detailed list, view our report

Market trend
Patient assistance programs
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Idiopathic Pulmonary Fibrosis to grow at a CAGR of 23.97% during 2016-2020 here

News-ID: 376596 • Views:

More Releases from Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis - Epidemiology Forecast To 2025
Summary The American Thoracic Society (ATS) defines IPF as a chronic, fibrosing interstitial pneumonia of unknown cause, which occurs primarily in older adults. IPF is characterized by variable degrees of inflammation and scarring and is associated with a histologic or radiologic pattern of usual interstitial pneumonia (UIP). IPF is the most common form of idiopathic interstitial pneumonia, having the worst prognosis, and only three to five years of median survival. IPF

More Releases for Technavio

Dual Lens Camera Smartphone Market - Technavio
The "Global Dual Lens Camera Smartphone Market by Price (premium range, medium range, and low range) and Geography (APAC, North America, Europe, South America, and MEA) - Forecast and Analysis 2021-2025" report has been added to Technavio's offering. With ISO 9001:2015 certification, Technavio is proudly partnering with more than 100 Fortune 500 companies for over 16 years. The dual-lens camera smartphone market share is expected to increase by USD 462.03
Technavio: Global Automotive Start-stop System Market
June 15, 2017 - Technavio’s latest report on the global automotive start-stop system market provides an analysis of the most important trends, drivers, and challenges expected to impact the market outlook from 2017-2021. This market research report includes up to date analysis, share breakdown, and projections for various application, end-user, product, distribution, and geographical segments. The report also provides an in-depth vendor landscape, covering various large and small stakeholders in
Fiber Channel over Ethernet (FCoE) Market Booming: TechNavio Report
TechNavio, the independent tech-focused global research firm, has published their report on the Global Fiber Channel over Ethernet (FCoE) Market. The market is growing at a CAGR of 37.73 percent from 2013-2018. An FCoE is a storage protocol that enables fiber channel communications over Ethernet. The use of FCoE consolidates network data transmission and reduces the complexity of data centers. FCoE transmission condenses fiber channel frames into Ethernet frames, which can
TechNavio Publishes Global Metal Organic Chemical Vapor Deposition (MOCVD) Equip …
TechNavio, the independent tech-focused global research firm, has announced the publication of its report on the Global Metal Organic Chemical Vapor Deposition Equipment Market, which is posting a CAGR of 14.13 percent from 2013-2018. Market growth in this area is being attributed to high demand for LED lighting, as MOCVD equipment is used in the production of LEDs. As this technology is used more and more frequently in consumer electronics
TechNavio Publishes Global Metal Organic Chemical Vapor Deposition (MOCVD) Equip …
TechNavio, the independent tech-focused global research firm, has announced the publication of its report on the Global Metal Organic Chemical Vapor Deposition Equipment Market, which is posting a CAGR of 14.13 percent from 2013-2018. Market growth in this area is being attributed to high demand for LED lighting, as MOCVD equipment is used in the production of LEDs. As this technology is used more and more frequently in consumer electronics
Global Hard Disk Drive Market Struggling for Growth: TechNavio Report
A recent report by TechNavio, the independent tech-focused global research firm, shows the Global Hard Disk Drive (HDD) Market is faltering in the presence of newer technologies like solid state drives (SSDs) and cloud storage. The market is only expecting growth of 0.13 percent CAGR through 2018. HDDs are comprised of one or more rotating disks, covered in magnetic material. While they are able to store a lot of data